Dimensional Fund Advisors’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-554,319
Closed -$21.1M 3355
2017
Q2
$21.1M Sell
554,319
-888,339
-62% -$39.6M 0.01% 1998
2017
Q1
$70.5M Sell
1,442,658
-27,845
-2% -$1.27M 0.03% 793
2016
Q4
$49.9M Sell
1,470,503
-30,267
-2% -$1.07M 0.02% 1124
2016
Q3
$56.6M Sell
1,500,770
-64,014
-4% -$2.41M 0.03% 911
2016
Q2
$52.6M Sell
1,564,784
-284,813
-15% -$10M 0.03% 919
2016
Q1
$58.8M Sell
1,849,597
-46,396
-2% -$1.52M 0.04% 739
2015
Q4
$70.8M Buy
1,895,993
+105,865
+6% +$4M 0.04% 562
2015
Q3
$68M Buy
1,790,128
+44,118
+3% +$1.55M 0.04% 552
2015
Q2
$50M Buy
1,746,010
+290,034
+20% +$8.08M 0.03% 864
2015
Q1
$40.8M Buy
1,455,976
+142,052
+11% +$3.99M 0.03% 1047
2014
Q4
$36.4M Buy
1,313,924
+134,375
+11% +$3.33M 0.02% 1101
2014
Q3
$26.3M Buy
1,179,549
+41,224
+4% +$1.05M 0.02% 1324
2014
Q2
$33.1M Sell
1,138,325
-550
-0% -$14.7K 0.02% 1095
2014
Q1
$32.4M Buy
1,138,875
+136,428
+14% +$4.51M 0.02% 1037
2013
Q4
$38.7M Buy
1,002,447
+37,677
+4% +$1.35M 0.03% 827
2013
Q3
$32.3M Sell
964,770
-1,568
-0.2% -$49.9K 0.03% 887
2013
Q2
$29.7M Buy
+966,338
New +$32.3M 0.03% 871

Other funds holding MDCO

Dimensional Fund Advisors's MDCO Position: Q3 2017 in Review

Dimensional Fund Advisors sold out of Medicines Co (MDCO) in Q3 2017, closing a stake of 554,319 shares — an estimated $21.1M sold.

Dimensional Fund Advisors first reported a position in MDCO in Q2 2013 and held it in 17 quarters. The position peaked at $70.8M in Q4 2015. 190 funds tracked by Wall St. Rank hold MDCO as of Q3 2017.

  • Dimensional Fund Advisors reported no remaining Medicines Co position as of Q3 2017 after selling out during the quarter.
  • Dimensional Fund Advisors sold 554,319 Medicines Co shares in Q3 2017, an estimated $21.1M.
  • Dimensional Fund Advisors first reported a position in Medicines Co in Q2 2013 and held it in 17 quarters.
  • Dimensional Fund Advisors's Medicines Co position peaked at $70.8M in Q4 2015.
  • 190 funds tracked by Wall St. Rank held Medicines Co as of Q3 2017.

Based on Dimensional Fund Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.